Literature DB >> 33968633

Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review.

Kristina Wasmer1, Lars Eckardt1, Helmut Baumgartner2, Julia Köbe1.   

Abstract

Arrhythmias are among the most common late complications in adults with congenital heart disease (ACHD) and a frequent reason for hospital admission. Both, supraventricular and ventricular arrhythmias, not only cause debilitating symptoms, but may be life-threatening by increasing risk of stroke, causing or worsening heart failure and being associated with sudden death. Substrate and risk for arrhythmia differs widely between congenital defects with specific arrhythmias being much more common in some patients than others. Atrial macroreentrant arrhythmias are particularly frequent in patients with atrial septal defects and repair that involves atrial incisions including patients with transposition of the great arteries (TGA) and atrial switch. Accessory pathways and related arrhythmias are often associated with Ebstein's anomaly and congenitally corrected TGA. Monomorphic ventricular arrhythmias occur in patients with ventricular incisions, namely patients with Tetralogy of Fallot. Changes in surgical repair techniques influence arrhythmia prevalence and substrate as well as anatomical access for catheter ablation procedures. In addition, epidemiologic changes associated with improved long-term survival will further increase the prevalence of atrial fibrillation in ACHD. This article summarizes current understanding of prevalence of specific arrhythmias, underlying mechanisms, medical and interventional treatment options and their outcome in ACHD. 2021 Cardiovascular Diagnosis and Therapy. All rights reserved.

Entities:  

Keywords:  Adult congenital heart disease (ACHD); antiarrhythmic drug therapy; catheter ablation; supraventricular tachycardia; ventricular tachycardia

Year:  2021        PMID: 33968633      PMCID: PMC8102262          DOI: 10.21037/cdt-20-634

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  61 in total

1.  ESC Guidelines for the management of grown-up congenital heart disease (new version 2010).

Authors:  Helmut Baumgartner; Philipp Bonhoeffer; Natasja M S De Groot; Fokko de Haan; John Erik Deanfield; Nazzareno Galie; Michael A Gatzoulis; Christa Gohlke-Baerwolf; Harald Kaemmerer; Philip Kilner; Folkert Meijboom; Barbara J M Mulder; Erwin Oechslin; Jose M Oliver; Alain Serraf; Andras Szatmari; Erik Thaulow; Pascal R Vouhe; Edmond Walma
Journal:  Eur Heart J       Date:  2010-08-27       Impact factor: 29.983

2.  Time Course of Atrial Fibrillation in Patients With Congenital Heart Defects.

Authors:  Christophe P Teuwen; Tanwier T T K Ramdjan; Marco Götte; Bianca J J M Brundel; Reinder Evertz; Joris W J Vriend; Sander G Molhoek; Henderikus G R Dorman; Jurren M van Opstal; Thelma C Konings; Pepijn van der Voort; Etienne Delacretaz; Charlotte Houck; Ameeta Yaksh; Luca J Jansz; Maarten Witsenburg; Jolien W Roos-Hesselink; John K Triedman; Ad J J C Bogers; Natasja M S de Groot
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-08-14

3.  Efficacy and adverse effects of sotalol in adults with congenital heart disease.

Authors:  Benjamin M Moore; Rachael L Cordina; Mark A McGuire; David S Celermajer
Journal:  Int J Cardiol       Date:  2018-06-20       Impact factor: 4.164

Review 4.  Insights on Atrial Fibrillation in Congenital Heart Disease.

Authors:  Mohammad A Ebrahim; Carolina A Escudero; Michal J Kantoch; Isabelle F Vondermuhll; Joseph Atallah
Journal:  Can J Cardiol       Date:  2018-08-14       Impact factor: 5.223

5.  Impact of atrial arrhythmias on outcome in adults with congenital heart disease.

Authors:  H Yang; J M Kuijpers; J R de Groot; T C Konings; A van Dijk; G Tj Sieswerda; M C Post; B J M Mulder; B J Bouma
Journal:  Int J Cardiol       Date:  2017-12-01       Impact factor: 4.164

6.  Novel oral anticoagulant use in adult Fontan patients: A single center experience.

Authors:  Justin Georgekutty; Amir Kazerouninia; YunFei Wang; Peter R Ermis; Dhaval R Parekh; Wayne J Franklin; Wilson W Lam
Journal:  Congenit Heart Dis       Date:  2018-03-24       Impact factor: 2.007

7.  Catheter Ablation for Atrial Fibrillation in Adults With Congenital Heart Disease: Lessons Learned From More Than 10 Years Following a Sequential Ablation Approach.

Authors:  Christian Sohns; Jan-Hendrik Nürnberg; Joachim Hebe; Wolfgang Duckeck; Rodolfo Ventura; Frank Konietschke; Cong Cao; Jürgen Siebels; Marius Volkmer
Journal:  JACC Clin Electrophysiol       Date:  2018-03-28

8.  The unnatural history of an atrial septal defect: longitudinal 35 year follow up after surgical closure at young age.

Authors:  Judith A A E Cuypers; Petra Opić; Myrthe E Menting; Elisabeth M W J Utens; Maarten Witsenburg; Wim A Helbing; Annemien E van den Bosch; Mohamed Ouhlous; Ron T van Domburg; Folkert J Meijboom; Ad J J C Bogers; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2013-07-25       Impact factor: 5.994

Review 9.  Drug Therapy in Adult Congenital Heart Disease.

Authors:  Tahmeed Contractor; Vadim Levin; Ravi Mandapati
Journal:  Card Electrophysiol Clin       Date:  2017-06

10.  Atrial arrhythmias in adults with congenital heart disease.

Authors:  Judith Bouchardy; Judith Therrien; Louise Pilote; Raluca Ionescu-Ittu; Giuseppe Martucci; Natalie Bottega; Ariane J Marelli
Journal:  Circulation       Date:  2009-10-12       Impact factor: 29.690

View more
  2 in total

1.  A novel KLF13 mutation underlying congenital patent ductus arteriosus and ventricular septal defect, as well as bicuspid aortic valve.

Authors:  Pradhan Abhinav; Gao-Feng Zhang; Cui-Mei Zhao; Ying-Jia Xu; Juan Wang; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2022-03-01       Impact factor: 2.447

Review 2.  Congenital Heart Disease: The State-of-the-Art on Its Pharmacological Therapeutics.

Authors:  Carlos Daniel Varela-Chinchilla; Daniela Edith Sánchez-Mejía; Plinio A Trinidad-Calderón
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.